BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Content Block Control
Share
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
CTSU MA.32
Principal Investigator:
Naughton, Michael
Title:
A Phase III Randomized Trial of Metformin Versus Placebo on Recurrence and Survival in Early Stage Breast Cancer
Phase:
III
Disease Site:
Breast, Female
Participating Site(s):
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
The purpose of this study is to find out whether it is better to receive the drug Metformin, with the usual treatment for breast cancer, or not. To do this, half of the subjects in this study will get Metformin, in addition to their usual treatment. The other half will receive a placebo (a substance that will look identical to the Metformin pills but will not contain any active ingredients) in addition to their usual treatment.
More Information:
(Links will take you off this web site)
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)